Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein

被引:0
|
作者
vonWeizsacker, F [1 ]
Wieland, S [1 ]
Blum, HE [1 ]
机构
[1] UNIV HOSP FREIBURG,DEPT MED,FREIBURG,GERMANY
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The hepatitis B virus (HBV) nucleocapsid consists of 240 viral core proteins that, are arranged in a highly symmetrical structure. HBV replication can only take place inside intact nucleocapsids. In the present study, we investigated whether genetically engineered core mutants can inhibit viral replication by interfering with the formation of intact nucleocapsids. Using the duck hepatitis B virus (DHBV) model, a series of core protein mutants was generated, Polymerase chain reaction-amplified fragments from the bacterial lacZ gene expressing up to 282 amino acids were added either to the amino- or carboxy-terminus of the DHBV core protein, In addition, carboxy-terminal extensions were generated by fusing the DHBV core protein with the DHBV small surface protein or various fragments of the viral polymerase, Finally, the green fluorescent protein (GFP) was fused in-frame to the carboxy-terminus of the DHBV core protein. In this chimeric protein, GFP is still functional and can act as a reporter molecule, The various core protein mutants were tested for their potential antiviral activity by cotransfection with a replication-competent DHBV construct into the avian hepatoma cell line LMH. Carboxy-terminal, but not amino-terminal, DHBV core mutants inhibited DHBV replication by up to 90% at an effector-to-target ratio of 1:10, thus displaying a dominant negative phenotype. Antiviral activity was species-specific and caused by posttranslational interference with viral replication, The DHBV core-GFP fusion protein should be an ideal tool to assess the antiviral potential of dominant negative core proteins tn vivo.
引用
收藏
页码:294 / 299
页数:6
相关论文
共 50 条
  • [1] INHIBITION OF VIRAL REPLICATION BY MUTANTS OF THE DUCK HEPATITIS-B VIRUS CORE PROTEIN
    VONWEIZSACKER, F
    WIELAND, S
    BLUM, HE
    HEPATOLOGY, 1995, 22 (04) : 648 - 648
  • [2] CHARACTERIZATION OF HEPATITIS-B VIRUS CORE MUTANTS THAT INHIBIT VIRAL REPLICATION
    SCAGLIONI, PP
    MELEGARI, M
    WANDS, JR
    HEPATOLOGY, 1994, 20 (04) : A265 - A265
  • [3] CHARACTERIZATION OF HEPATITIS-B VIRUS CORE MUTANTS THAT INHIBIT VIRAL REPLICATION
    SCAGLIONI, PP
    MELEGARI, M
    WANDS, JR
    VIROLOGY, 1994, 205 (01) : 112 - 120
  • [4] Prosphorylation of the duck hepatitis B virus core protein is required for viral uncoating
    Kòck, J
    Kann, M
    Pütz, G
    Blum, HE
    von Weizsäcker, F
    HEPATOLOGY, 2002, 36 (04) : 370A - 370A
  • [5] Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein
    Han, Jinchao
    Pan, Xiaoben
    Gao, Yan
    Weil, Lai
    VIRUS RESEARCH, 2010, 150 (1-2) : 129 - 134
  • [6] Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis
    von Weizsäcker, F
    Köck, J
    Wieland, S
    Offensperger, WB
    Blum, HE
    HEPATOLOGY, 1999, 30 (01) : 308 - 315
  • [7] Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein
    Chen, SY
    Kao, CF
    Chen, CM
    Shih, CM
    Hsu, MJ
    Chao, CH
    Wang, SH
    You, LR
    Lee, YHW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) : 591 - 607
  • [8] Inhibition of duck hepatitis B virus replication by mimic peptides in vitro
    Jia, Hongyu
    Liu, Changhong
    Yang, Ying
    Zhu, Haihong
    Chen, Feng
    Liu, Jihong
    Zhou, Linfu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1697 - 1703
  • [9] INHIBITION OF DUCK HEPATITIS-B VIRUS-REPLICATION BY HYPERICIN
    MORALEDA, G
    WU, TT
    JILBERT, AR
    ALDRICH, CE
    CONDREAY, LD
    LARSEN, SH
    TANG, JC
    COLACINO, JM
    MASON, WS
    ANTIVIRAL RESEARCH, 1993, 20 (03) : 235 - 247
  • [10] Hepatitis B virus core protein dimer-dimer interface is critical for viral replication
    Zheng, Chang-Long
    Fu, Yong-Mei
    Xu, Zhan-Xue
    Zou, Yong
    Deng, Kai
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 262 - 270